Use of PHENYLEPHRINE, solution for injection
Conditions
Interventions
Group 1: Employee survey of 200 employees on the labeling, handling and storage of syringes with phenylephrine (100 pre-filled syringes with and 100 ampoules)
Sponsors
Charité - Universitätsmedizin Berlin Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, CCM/CVK, Campus Virchow- Klinikum
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Anesthesiologists working in the delivery room
Exclusion criteria
Exclusion criteria: Rejektion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of the employee survey is the evaluation of the labeling, handling and storage of syringes with phenylephrine | — |
Secondary
| Measure | Time frame |
|---|---|
| Desciption: Evaluation of packaging / storage Evaluation of the inscription Evaluation of the dosability Evaluation the pregnancy week Evaluation of the type of sectio Evaluation of the AGPAR scores Evaluation of the pH value of the newborn [ Time Frame: Participants will be followed up to until the end of the operation ] Reasons for the use of the crushing pellets phenylephrine, manufactured by Sintetica Reasons for the use of the syringe Phenylephrine, manufactured by Aguettant | — |
Countries
Germany
Contacts
Public ContactThomas Ocker
Charité - Universitätsmedizin Berlin Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, CCM/CVK, Campus Virchow- Klinikum
Outcome results
None listed